News and Reports

Globe
  • HBM Partners successful trade sale of Swiss biotech company ESBATech to Alcon

    14 September 2009
    Download
  • PTC Therapeutics initiates registration-directed Phase 3 trial of Ataluren in Cystic Fibrosis

    10 September 2009
    Download
  • MiCardia announces completion of enrollment in “DYANA” European CE study

    4 September 2009
    Download
  • Successful sale of BRAHMS in an all-cash transaction to Thermo Fisher Scientific: Net profit for HBM advised antities of EUR 134.2 million, or 21.6 times the invested equity

    3 September 2009
    Download
  • PTC Therapeutics announces achievement of major milestone in Schering- Plough Hepatitis C collaboration

    10 August 2009
    Download
  • Zosana Pharma, Inc. secures $30 million in new round of financing

    7 July 2009
    Download
  • Brahms - New cardiac marker copeptin accelerates diagnosis of acute myocardial infarction (AMI)

    2 July 2009
    Download
  • Sloning BioTechnology and Henkel to cooperate in enzyme development

    30 June 2009
    Download
  • Brahms - Cezanne and Lumiphore announces partnership for diagnostic tests

    22 June 2009
    Download
  • Vivacta raises $4.5 million to commercialise piezofilm technology

    16 June 2009
    Download
  • MiCardia announces first U.S. implant

    16 June 2009
    Download
  • Devax receives IDE approval to commence bifurcation stent trial

    29 May 2009
    Download
  • mtm laboratories and MetaSystems agree on partnership to develop Automated CINtec Cytology Imaging System

    26 May 2009
    Download
  • Brahms - for the first time, a new Biomarker test enables detection of Alzheimer's dementia in blood

    15 May 2009
    Download
  • Diagnostics company BRAHMS presents positive results for 2008

    13 May 2009
    Download
  • Merck KGaA, global partner of Newron, initiates second phase III trial of safinamide in advanced Parkinson's disease

    7 May 2009
    Download
  • Anthera's varespladib meets primary endpoint in phase 2 FRANCIS trial for the treatment of acute coronary syndrome

    6 May 2009
    Download
  • Ophthotech's positive results for their Novel Therapy for Wet AMD

    4 May 2009
    Download
  • Lux reports first oral drug for uveitis which reduces both inflammation and recurrence rate in potientially blinding eye disease

    4 May 2009
    Download
  • Mpex's new CBO Mark Wiggins joins from Biogen Idec

    20 April 2009
    Download
  • Lux Biosciences reports positive results from LUMINATE Phase 3 program of LX211 (LUVENIQ) in Uveitis

    26 March 2009
    Download
  • ESBATech ESBA105 demonstrates efficacy in the back of the eye to inhabit neovascularization

    24 March 2009
    Download
  • Anthera's IMPACTS trial demonstrates favorable interim results in preventing sickle cell complication

    24 March 2009
    Download
  • Nereus Pharmaceuticals initiates randomized phase 2 clinical trial in non-small cell lung cancer

    23 March 2009
    Download
  • MiCardia announces worlds' first dynamic heart valve repair on a beating heart

    17 February 2009
    Download